G
Geoffrey van den Brande
Researcher at University of California, San Diego
Publications - 3
Citations - 558
Geoffrey van den Brande is an academic researcher from University of California, San Diego. The author has contributed to research in topics: Randomized controlled trial & Placebo. The author has an hindex of 3, co-authored 3 publications receiving 520 citations.
Papers
More filters
Journal ArticleDOI
Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial.
Ronald J. Ellis,Will Toperoff,Florin Vaida,Geoffrey van den Brande,James Gonzales,Ben Gouaux,Heather Bentley,J. Hampton Atkinson +7 more
TL;DR: Smoked cannabis was generally well tolerated and effective when added to concomitant analgesic therapy in patients with medically refractory pain due to HIV DSPN.
Journal ArticleDOI
Lithium improves HIV-associated neurocognitive impairment.
Scott Letendre,Steven Paul Woods,Ronald J. Ellis,J. Hampton Atkinson,Eliezer Masliah,Geoffrey van den Brande,Janis Durelle,Igor Grant,Ian P. Everall +8 more
TL;DR: Lithium resulted in improved neuropsychological performance in antiretroviral-treated, impaired individuals in this small, open-label study, and lithium may exert this effect by inhibiting neuronal glycogen synthase kinase-3β.
Journal ArticleDOI
Characterization of Interference with 6 Commercial Δ9-Tetrahydrocannabinol Immunoassays by Efavirenz (Glucuronide) in Urine
Steven S. Rossi,Tony L. Yaksh,Heather Bentley,Geoffrey van den Brande,Igor Grant,Ronald J. Ellis +5 more
TL;DR: It is hypothesized that cross-reactivity with THC immunoassays was the result of the interaction of EFV metabolite (and not a parent drug) with the antibody complexes used in antibodies used to screen for THC exposure.